Stockreport

Volition Issues Business Review 2023 [Yahoo! Finance]

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF Volition's major achievements in 2023 include: Launching the Nu.Q® Vet Cancer Test in some significant markets through several licensing, supply and/or distribution a [Read more]